Juvista (Avotermin) in Breast Reduction Surgery Scars

Status Terminated

Clinical Trial Summary

Severe scarring is a common problem following breast reduction surgery, studies have shown that over 64% of patients develop a hypertrophic scar at three months after the operation. Scar severity can be influenced by a large number of factors including age, sex, skin thickness and tension, ethnicity and the position of the scar on the body. Therefore the most sensitive and reliable method to assess the efficacy of an anti-scarring treatment is to compare bilateral wounds on the same individual. Bilateral breast reduction surgery provides an ideal model for a within patient evaluation of anti-scarring activity in wounds which develop into bad scars.

This study is being undertaken to investigate the efficacy and safety of Juvista (given as an intradermal injection of 200ng per 1cm wound margin) in the reduction of scar appearance applied to approximated wound margins following bilateral reduction mammaplasty.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00432328
Study type	Interventional
Source	Renovo
Contact
Status	Terminated
Phase	Phase 2
Start date	October 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02672956` - Comparison of Different Umbilical Port Entry Techniques in Terms of Cosmetic Results	N/A
Completed	`NCT02645773` - Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring	N/A
Completed	`NCT00629811` - Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women	Phase 2
Completed	`NCT00977951` - Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects	Phase 1/Phase 2
Completed	`NCT00847795` - Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.	Phase 1/Phase 2
Not yet recruiting	`NCT03213548` - Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty	N/A
Recruiting	`NCT05377723` - Abdominal Scar Improvement in Microsurgical Breast Reconstruction	N/A
Active, not recruiting	`NCT01976260` - A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars	N/A
Completed	`NCT00984503` - Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites	Phase 2
Completed	`NCT00594581` - Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males	Phase 2
Recruiting	`NCT04420442` - Scar Resection and Reconstruction With Integra and Split Skin Grafts in Patients With Non-Suicidal Self-Inflicted Scars	N/A
Completed	`NCT02772289` - Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars	Phase 2
Completed	`NCT00430326` - Juvista (Avotermin) in Scars Following Varicose Vein Removal	Phase 2
Completed	`NCT00847925` - Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects	Phase 1/Phase 2
Recruiting	`NCT05787171` - Three Sutures With Different Absorption Rates for Lower Abdominal Incision	N/A
Completed	`NCT02985151` - Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy	N/A
Completed	`NCT02340325` - FS2 Safety and Tolerability Study in Healthy Volunteers	Phase 1
Active, not recruiting	`NCT00432211` - Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.	Phase 2
Completed	`NCT00978302` - Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)	Phase 1
Withdrawn	`NCT04034615` - The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars	Phase 2